Agile Therapeutics Inc (AGRX)

0.384 -0.02 (-5.14%) USD  |  OTCM  |  May 03, 16:00
More

Agile Therapeutics Cash and Short Term Investments (Quarterly): 2.557M for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2013. Upgrade now.
Date Value
December 31, 2023 2.557M
September 30, 2023 2.873M
June 30, 2023 2.785M
March 31, 2023 4.429M
December 31, 2022 5.246M
September 30, 2022 6.145M
June 30, 2022 13.03M
March 31, 2022 3.743M
December 31, 2021 19.14M
September 30, 2021 14.74M
June 30, 2021 31.12M
March 31, 2021 40.11M
December 31, 2020 54.47M
September 30, 2020 71.90M
June 30, 2020 87.24M
March 31, 2020 93.92M
December 31, 2019 34.48M
September 30, 2019 18.37M
June 30, 2019 10.59M
March 31, 2019 11.56M
December 31, 2018 7.851M
Date Value
September 30, 2018 16.93M
June 30, 2018 22.46M
March 31, 2018 28.34M
December 31, 2017 35.95M
September 30, 2017 43.81M
June 30, 2017 33.94M
March 31, 2017 41.74M
December 31, 2016 48.75M
September 30, 2016 51.67M
June 30, 2016 59.22M
March 31, 2016 65.50M
December 31, 2015 34.40M
September 30, 2015 39.40M
June 30, 2015 46.41M
March 31, 2015 53.87M
December 31, 2014 40.18M
September 30, 2014 45.68M
June 30, 2014 53.49M
March 31, 2014 3.01M
December 31, 2013 2.120M

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

2.557M
Minimum
Dec 2023
93.92M
Maximum
Mar 2020
27.20M
Average
14.74M
Median
Sep 2021

Cash and Short Term Investments (Quarterly) Benchmarks

Altimmune Inc 197.82M
iBio Inc 2.788M
Verastem Inc 137.13M
Oragenics Inc 3.484M
Actinium Pharmaceuticals Inc 84.06M